Home / Get Clarity / Positioning and messaging
Life Science Positioning and Messaging
Positioning decides how your company should be understood. Messaging turns that into words each audience acts on. You get a clear position and audience-specific messages, grounded in credible scientific evidence.
For biotech, medtech, diagnostics, CRO, CDMO and scientific instrument companies.
· Biotech science messaging
One scientific claim, told three ways
Each audience decides on different evidence. Good biotech messaging keeps the science accurate and changes what comes first.
The science
Our assay detects the target biomarker at femtomolar levels in under 20 minutes.
Illustrative example
For investors
A diagnosis in one visit instead of a week, in a market where speed decides adoption.
For partners
A validated detection platform you can license for your own biomarker panels.
For lab buyers
Results while the patient is still in the clinic, on the instruments you already run.
· How we work
How to position complex life science innovation
Three steps. Each one ends in something ready to use.
Market and audience insight
We review your science, competitors and how investors, partners and customers see you today.
OutputAudience and competitor map
Positioning decision
We find what is truly different, the data that proves it, and the market, segment and position you can defend.
OutputClaims ranked by evidence and a written positioning statement
Messages per audience
Investors, partners and customers each get the version that matters to them, ready for your website, deck, talks and sales calls.
OutputMessaging pillars, audience frameworks and a guide with approved language
· Investor messaging
Life science messaging investors can follow
Investors see the science and the commercial case in the same few minutes. Your story has to clarify both without overselling either.
- Your science explained in plain terms, without losing accuracy
- Why it wins against current approaches, backed by your data
- One narrative for your pitch deck and investor web pages
· Deliverables and results
What you receive and what changes
What you receive
Three documents you own
- Positioning statement for scientific, commercial and investor contexts
- Core messaging pillars that hold up across audiences
- A technology description non-specialists can evaluate
What changes
One story, everywhere
- Investors see scientific credibility and commercial potential together
- Website, deck, and sales calls say the same thing
- New content starts from approved language, so less gets rewritten
· Who it's for
Life science positioning support is for you if
- You are preparing to raise and investors don't see why your science wins.
- You run an instrument, CRO, CDMO or diagnostics business moving into a new market.
- Competitors make similar claims and you sound like them.
· Use it next
Where positioning leads
· Contact
Tell us where you're stuck.
One conversation. You leave with a clearer next step, whether or not we work together.
We only use your details to reply. Privacy policy
· FAQ
Biotech positioning and messaging questions
The decision about how your company and technology should be understood: which market you compete in, which segment you serve and why you are the better choice there. Messaging, content and design all build on it.
Positioning is the decision. Messaging is the language that expresses it for each audience. We write both, in that order, so the messages stay consistent.
We start from your data and decide what each audience needs to evaluate. The claims stay accurate; the order and level of detail change. Every message is checked for scientific accuracy before it is used.
A few weeks for most companies. Research and the evidence review take the most time. A short scoping call gives you a firm timeline.
Yes, ideally. Both are faster to build when the positioning and approved language already exist, and they won't need rewriting later.
Yes. Besides therapeutics and platform biotechs, we position instrument, CRO, CDMO, diagnostics and research service businesses, often when they move into a new market or segment.